<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35094669</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in <i>Mycoplasma pneumoniae</i> pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>593</StartPage>
          <EndPage>605</EndPage>
          <MedlinePgn>593-605</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2036582</ELocationID>
        <Abstract>
          <AbstractText>Although previous studies have reported the use of metabolomics for infectious diseases, little is known about the potential function of plasma metabolites in children infected with <i>Mycoplasma pneumoniae</i> (MP). Here, a combination of liquid chromatography-quadrupole time-of-flight mass spectrometry and random forest-based classification model was used to provide a broader range of applications in MP diagnosis. In the training cohort, plasma from 63 MP pneumonia children (MPPs), 37 healthy controls (HC) and 29 infectious disease controls (IDC) was collected. After multivariate analyses, 357 metabolites were identified to be differentially expressed among MPP, HC and IDC groups, and 3 metabolites (568.5661, 459.3493 and 411.3208) had high diagnostic values. In an independent cohort with 57 blinded subjects, samples were successfully classified into different groups, demonstrating the reliability of these biomarkers for distinguishing MPPs from controls. A metabolomic signature analysis identified major classes of glycerophospholipids, sphingolipids and fatty acyls were increased in MPPs. These markedly altered metabolites are mainly involved in glycerophospholipid and sphingolipid metabolism. As the ubiquitous building blocks of eukaryotic cell membranes, dysregulated lipid metabolism indicates damage of the cellular membrane and the activation of immunity in MPPs. Moreover, lipid metabolites, differentially expressed between severe and mild MPPs, were correlated with the markers of extrapulmonary complications, suggesting that they may be involved in MPP disease severity. These findings may offer new insights into biomarker selection and the pathogenesis of MPP in children.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jieqiong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Disease, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luu</LastName>
            <ForeName>Laurence Don Wai</ForeName>
            <Initials>LDW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiaoxia</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Central &amp; Clinical Laboratory of Sanya People's Hospital, Sanya, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>XiaoDai</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Research Center, Capital Institute of Pediatrics, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xiaolan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Research Center, Capital Institute of Pediatrics, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Jin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Research Center, Capital Institute of Pediatrics, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Xiong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Central &amp; Clinical Laboratory of Sanya People's Hospital, Sanya, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhenjun</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Research Center, Capital Institute of Pediatrics, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tai</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Head and Neck Surgery, Children's Hospital Capital Institute of Pediatrics, Beijing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="Y">Mycoplasma pneumoniae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae pneumonia; metabolomics</Keyword>
        <Keyword MajorTopicYN="N">children</Keyword>
        <Keyword MajorTopicYN="N">diagnosis</Keyword>
        <Keyword MajorTopicYN="N">pathogenesis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>5</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35094669</ArticleId>
        <ArticleId IdType="pmc">PMC8865114</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2022.2036582</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Waites KB, et al. . 
Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev.
2017;30(3):747–809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5475226</ArticleId>
            <ArticleId IdType="pubmed">28539503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, et al. . 
Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4697461</ArticleId>
            <ArticleId IdType="pubmed">25714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Izumikawa K.
Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia. Front Microbiol. 2016;7:800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4888638</ArticleId>
            <ArticleId IdType="pubmed">27313568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bajantri B, Venkatram S, Diaz-Fuentes G.. 
Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10(7):535–544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5997415</ArticleId>
            <ArticleId IdType="pubmed">29904437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KL, et al. . 
Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. J Formos Med Assoc. 2021;120(1 Pt 1):281–291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32948415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudkjøbing VB, et al. . 
Comparing culture and molecular methods for the identification of microorganisms involved in necrotizing soft tissue infections. BMC Infect Dis. 2016;16(1):652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5100109</ArticleId>
            <ArticleId IdType="pubmed">27821087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Totten AH, et al. . 
Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniae. J Clin Microbiol. 2019;57(6).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6535612</ArticleId>
            <ArticleId IdType="pubmed">30971463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai ZH, et al. . 
Diagnosis of Mycoplasma pneumoniae by loop-mediated isothermal amplification: systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6379949</ArticleId>
            <ArticleId IdType="pubmed">30782134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Captur G, et al. . 
Identification of a multiplex biomarker panel for hypertrophic cardiomyopathy using quantitative proteomics and machine learning. Mol Cell Proteomics. 2020;19(1):114–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6944230</ArticleId>
            <ArticleId IdType="pubmed">31243064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu HW, et al. . 
Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Mol Cell Proteomics. 2019;18(9):1796–1806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6731081</ArticleId>
            <ArticleId IdType="pubmed">31253657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel SK, et al. . 
Rapid discrimination of malaria- and dengue-infected patients sera using Raman spectroscopy. Anal Chem. 2019;91(11):7054–7062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31033270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adu-Gyamfi CG, et al. . 
Plasma indoleamine 2, 3-dioxygenase, a biomarker for tuberculosis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2017;65(8):1356–1358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5848309</ArticleId>
            <ArticleId IdType="pubmed">29017244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, et al. . 
Prospective serum metabolomic profiling of lethal prostate cancer. Int J Cancer. 2019;145(12):3231–3243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6698432</ArticleId>
            <ArticleId IdType="pubmed">30779128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carter TC, et al. . 
Validation of a metabolite panel for early diagnosis of type 2 diabetes. Metabolism. 2016;65(9):1399–1408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5518599</ArticleId>
            <ArticleId IdType="pubmed">27506746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song JW, et al. . 
Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32(2):188–202. e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7311890</ArticleId>
            <ArticleId IdType="pubmed">32610096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buzatto A. Z, et al. . 
Comprehensive lipidomic and metabolomic analysis for studying metabolic changes in lung tissue induced by a vaccine against Respiratory syncytial virus. ACS Infect Dis. 2020;6(8):2130–2142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32633123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhargava P, Anthony DC.. 
Metabolomics in multiple sclerosis disease course and progression. Mult Scler. 2020;26(5):591–598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31965880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peña-Bautista C, et al. . 
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker. J Proteomics. 2019;200:144–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30978462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monteiro MS, et al. . 
Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem. 2013;20(2):257–271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23210853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Channappanavar R, Perlman S.. 
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529–539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7079893</ArticleId>
            <ArticleId IdType="pubmed">28466096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Subspecialty Group of Respiratory Diseases . The society of pediatrics, C.M.A.E.B., Chinese journal of pediatrics., guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I) [in Chinese]. Zhonghua. Er. Ke. Za. Zhi. 2013;51:745–752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24406226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, et al. . 
Screening and Identification of APOC1 as a novel potential biomarker for differentiate of Mycoplasma pneumoniae in children. Front Microbiol. 2016;7:1961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5156883</ArticleId>
            <ArticleId IdType="pubmed">28018301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu XR, et al. . 
Plasma metabolomic profiling of proliferative diabetic retinopathy. Nutr Metab (Lond. 2019;16:37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6540396</ArticleId>
            <ArticleId IdType="pubmed">31160916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang QJ, et al. . 
Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J Cachexia Sarcopenia Muscle. 2018;9(1):71–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5803608</ArticleId>
            <ArticleId IdType="pubmed">29152916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu P, et al. . 
The trans-omics landscape of COVID-19. Nat Commun. 2021;12(1):4543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8316550</ArticleId>
            <ArticleId IdType="pubmed">34315889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maceyka M, Spiegel S.. 
Sphingolipid metabolites in inflammatory disease. Nature. 2014: 510), (7503): p. 58-67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4320971</ArticleId>
            <ArticleId IdType="pubmed">24899305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hishikawa D, et al. . 
Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J Lipid Res. 2014;55(5):799–807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3995458</ArticleId>
            <ArticleId IdType="pubmed">24646950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng C, et al. . 
Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience. 2017;6(10):1–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5647792</ArticleId>
            <ArticleId IdType="pubmed">29046044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He J, et al. . 
Insights into the pathogenesis of Mycoplasma pneumoniae (review). Mol Med Rep. 2016;14(5):4030–4036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5101875</ArticleId>
            <ArticleId IdType="pubmed">27667580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C, et al. . 
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol. 2020;32(7):857–866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7269023</ArticleId>
            <ArticleId IdType="pubmed">31714387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, et al. . 
Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection. BMC Microbiol. 2014;14:27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3922035</ArticleId>
            <ArticleId IdType="pubmed">24507763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizuno H, et al. . 
The great importance of normalization of LC-MS data for highly-accurate non-targeted metabolomics. Biomed Chromatogr. 2017;31(1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27718276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song Q, Xu BP, Shen KL.. 
Bacterial co-infection in hospitalized children with Mycoplasma pneumoniae pneumonia. Indian Pediatr. 2016;53(10):879–882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27771667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JH, et al. . 
Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients. J Thorac Dis. 2018;10(11):6118–6127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6297417</ArticleId>
            <ArticleId IdType="pubmed">30622783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, et al. . 
Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect. 2018;146(11):1384–1388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29970200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klement ML, et al. . 
A processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune response. Mol Microbiol. 2007;65(6):1444–1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17697098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravid T, et al. . 
Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol. 2003;284(6):L1082–L1092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4370276</ArticleId>
            <ArticleId IdType="pubmed">12576296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamocki K, et al. . 
RTP801 is required for ceramide-induced cell-specific death in the murine lung. Am J Respir Cell Mol Biol. 2013;48(1):87–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547084</ArticleId>
            <ArticleId IdType="pubmed">23024063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldkorn T, Chung S, Filosto S.. 
Lung cancer and lung injury: the dual role of ceramide. Handb Exp Pharmacol. 2013;216:93–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4370279</ArticleId>
            <ArticleId IdType="pubmed">23563653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Alwani M, et al. . 
Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther. 2006;112(1):171–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16759708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenck M, et al. . 
Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys. 2007;462(2):171–175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17467652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balish MF, et al. . 
Localization of Mycoplasma pneumoniae cytadherence-associated protein HMW2 by fusion with Green fluorescent protein: implications for attachment organelle structure. Mol Microbiol. 2003;47(1):49–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12492853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bansal P, Gaur SN, Arora N.. 
Lysophosphatidylcholine plays critical role in allergic airway disease manifestation. Sci Rep. 2016;6:27430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4901285</ArticleId>
            <ArticleId IdType="pubmed">27282246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sevastou I, et al. . 
Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta. 2013;1831(1):42–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22867755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang Y, et al. . 
Lipidomic profiling reveals triacylglycerol accumulation in the liver during pregnane X receptor activation-induced hepatomegaly. J Pharm Biomed Anal. 2021;195:113851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33387840</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
